LANSOPRAZOLE, LANSOPRAZOLE, Placebo to match lansoprazole high dose, Linaprazan glurate, Placebo to match Lansoprazole low dose, Placebo to match Linaprazan Glurate
CX842A2303
Phase 3 small_molecule active
Quick answer
LANSOPRAZOLE, LANSOPRAZOLE, Placebo to match lansoprazole high dose, Linaprazan glurate, Placebo to match Lansoprazole low dose, Placebo to match Linaprazan Glurate for Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active